Epsilon M&A Deal Report - Cross Pharma
Transaction Multiples for the Valuation of Private Companies
Unimedic / Cross Pharma
No EMAT :
66901
Announced Date :
25/06/2013
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Unimedic
Target :
Cross Pharma
Country :
Sweden
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Cross Pharma AB distributes pharmaceutical products in Sweden . > Engaged in the parallel imports of pharmaceuticals : it imports original pharmaceuticals from EU countries where the price level is...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
ns | ns |
|
||
| Current |
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 29/09/2014 | Private group led by LBO France | Payot (Laboratoires Dr NG Payot) | France | ** | 66660 |
| 30/07/2014 | Tecan Group | IBL International | Germany | ** | 66497 |
Source: Epsilon Research / EMAT
